Literature DB >> 1135611

Bone loss in patients with rheumatoid arthritis.

A C Kennedy, D A Smith, W W Buchanan, J B Anderson, M K Jasani.   

Abstract

Both male and female patients with rheumatoid arthritis show a significant bone loss in the femur, compared with the loss of bone seen in normal subjects with increasing age. A very similar pattern is seen in corticosteroid treated patients with rheumatoid arthritis. There is no evidence to suggest that the corticosteroid therapy has caused a greater loss of bone from the femur than would have occurred as a result of the rheumatoid arthritis alone. There was a statistically significant relation between the duration of the rheumatoid arthritis and femoral bone lo-s in women over the age of 45 years, whether or not they had been given steroid therapy in both male and female patients over 45 years of age, but again it appears unlikely that corticosteroid therapy had contributed significantly to the femoral bone loss. The Metacarpal and Femoral Indices of the patients were significantly related in both male and female groups.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1135611     DOI: 10.3109/03009747509095618

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  10 in total

1.  Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage.

Authors:  Mona Helmy Abdel Meguid; Yousry Hasan Hamad; Rania Shafek Swilam; Mohamed Samy Barakat
Journal:  Rheumatol Int       Date:  2012-04-25       Impact factor: 2.631

2.  Radiological evaluation of erosions: a quantitative method for assessing long-term remittive therapy in rheumatoid arthritis.

Authors:  W M O'Brien
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 3.  Osteoporosis in rheumatoid arthritis.

Authors:  Y Suzuki; Y Mizushima
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids.

Authors:  A Verstraeten; J Dequeker
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

5.  Biomarks in secondary osteoporosis.

Authors:  A Aroso Dias; A Lopes Vaz; M Hargreaves; C Afonso; D Araújø; T Bravo
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

6.  Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis.

Authors:  V J Hajiroussou; M Webley
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

7.  Bone metabolism in rheumatoid arthritis compared with postmenopausal osteoporosis.

Authors:  R M van Soesbergen; P Lips; A van den Ende; J K van der Korst
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

8.  Generalized osteoporosis in non-steroid treated rheumatoid arthritis.

Authors:  M Magaro; A Tricerri; D Piane; A Zoli; F Serra; L Altomonte; L Mirone
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

9.  Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?

Authors:  O S Als; A Gotfredsen; B J Riis; C Christiansen
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

10.  Gold salts inhibit osteoclastic bone resorption in vitro.

Authors:  T J Hall; H Jeker; H Nyugen; M Schaeublin
Journal:  Inflamm Res       Date:  1996-05       Impact factor: 4.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.